Adamis Pharmaceuticals Corp expected to post a loss of 3  cents a share - Earnings Preview

DMK Pharmaceuticals

14/05/2022 02:40

* Adamis Pharmaceuticals Corp  ADMP.OQ   ADMP.O  is expected
to report  results on May 16. 
    * ​Refinitiv's mean analyst estimate for Adamis
Pharmaceuticals
Corp is for a loss of 3 cents per share. For the same quarter
last year, the company reported a loss of 12 cents per share.
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated May 14 at 01:40 GMT.  All
figures in US dollars  unless otherwise stated